Clinerion has extended its patient coverage in Brazil to three new hospitals with the help of partner iHealth Group. This raises the footprint of Clinerion's Patient Network Explorer to 22 healthcare organisations and over 8 million patients in Brazil.
BASEL, Switzerland, April 19, 2022 /PRNewswire-PRWeb/ -- The three newest Brazilian hospitals to join the global community of partner hospitals on Clinerion's Patient Network Explorer platform are:
- Santa Casa de Misericórdia, Belo Horizonte, Minas Gerais
- Hospital Tacchini, Bento Gonçalves, Rio Grande do Sul
- UOPECCAN – União Oeste Paranaense de Estudos e Combate ao Câncer, also known as the Hospital do Câncer, Cascavel, Paraná
The hospital network in Brazil comprises hospitals of varied sizes, locations and specializations.
Through Patient Network Explorer, patients in Brazil are visible to international clinical trials sponsors, increasing the likelihood of their hospital being selected as a trial site and their being accepted to join trials of next generation treatments. Joining the Patient Network Explorer platform brings physicians and researchers at partner hospitals additional opportunities to offer innovative medical care to patients.
Clinerion matches academic and sponsored trials with clinical trial sites on the Patient Network Explorer platform, according to electronic health records (EHRs) at the sites. The system supports the search and identification of candidates for clinical trial recruitment by querying the EHRs in hospital information systems, i.e. demographics, medications, diagnoses, laboratory test results and procedures, without compromising patient privacy. Clinerion's global patient network currently covers over 248 million patients in hospitals in 24 countries around the world, including major clusters in Turkey, Poland, and Brazil. Access to this real-world data supports site selection and recruitment for randomized clinical trials (RCTs), and the generation of real-world evidence.
"We have always said that patients are at the center of everything that we do, and we are pleased to have established a strong coverage in Brazil to support patients in the country," says Barış Erdoğan, CEO of Clinerion. "As we expand, we become able to offer more and more real-world data useful for the development of next generation treatments and procedures."
iHealth Group supports the expansion of Clinerion's coverage in Brazil and the fulfilment of Clinerion's services inside the country. "If we had something positive in the COVID-19 pandemic, it is that science and clinical research are much more valued by people and governments, and we are very proud to have been the pioneers in bringing a technology solution to assist clinical research in Brazil," says Leonardo Nunes Alegre, COO of iHealth.
Details of the three new hospitals:
- Santa Casa de Misericórdia de Belo Horizonte: Santa Casa de Misericórdia is a reference hospital and one of the largest in Brazil, with more than 1000 beds (the largest in the state of Minas Gerais). The hospital receives patients from 80% of Minas Gerais municipalities and is the largest hospital and largest provider of services to SUS [the Brazilian national health system], in Minas Gerais. In 2017, it received more than 100 patients from other states. It has 170 ICU beds (the largest number in a single hospital in the country), 19 operating rooms for medium and high complexity procedures, and covers 35 medical specialties.
- Hospital Tacchini: The Hospital Tacchini offers a total of 301 beds in inpatient units, of which 136 are for the SUS [the Brazilian national health system], the rest for health insurance and private individuals. The research center at that hospital participated in the trials of the Coronavac vaccine for COVID-19.
- UOPECCAN: União Oeste Paranaense de Estudos e Combate ao Câncer, also known as Hospital do Câncer de Cascavel, is an NGO created in 1991, in the Brazilian municipality of Cascavel, in the Western Region of Paraná, which maintains two hospital units specialized in oncology, one in the main municipality (140 beds) and another in Umuarama (235 beds), in the Northwest Region of Paraná.
The full list of hospitals in Brazil on the Patient Network Explorer platform is:
Site name City State
MedRadius Maceio Alagoas
Hospital Portugues da Bahia Salvador Bahia
Hospital Martagão Gesteira (Liga Álvaro Bahia) Salvador Bahia
Hospital Ana Nery Salvador Bahia
Hospital Estadual de Criança (HEC) Feira de Santana Bahia
CRIO-Centro Regional Integrado de Oncologia Fortaleza Ceará
Hospital Felicio Rocho Belo Horizonte Minas Gerais
Santa Casa de Misericordia de Belo Horizonte Belo Horizonte Minas Gerais
Hospital Angelina Caron Campina Grande do Sul Paraná
UOPECCAN Cascavel Paraná
Hospital Sao Vicente de Paulo Passo Fundo Rio Grande do Sul
Santa Casa de Misericordia de Porto Alegre Porto Alegre Rio Grande do Sul
Hospital Ernesto Dornelles Porto Alegre Rio Grande do Sul
Hospital São Lucas da PUCRS Porto Alegre Rio Grande do Sul
Hospital Tacchini Bento Gonçalves Rio Grande do Sul
Hospital Regional do Oeste Chapeco Santa Catarina
Hospital PUC-Campinas Campinas São Paulo
Hospital Amaral Carvalho Jaú São Paulo
Clinico Ribeirao Preto (CAPED) Ribeirão Preto São Paulo
Cancer Institute Dr. Arnaldo Vieira De Carvalho São Paulo São Paulo
A.C. Camargo Cancer Center São Paulo São Paulo
Hospital Infantil Sabará São Paulo São Paulo
Clinerion and iHealth Group will next showcase the capabilities of the Patient Network Explorer network in Brazil at a face-to-face event entitled "AI in Clinical Research - How to innovate with the patient in mind" on April 26, 2022, in São Paulo.
About Clinerion
Clinerion accelerates clinical research and medical access to treatments for patients. We generate real-world data from our global network of partner hospitals for Real World Evidence analyses. Clinerion's Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments.
Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. Researchers gain access to real-time, longitudinal patient data from electronic health records for analysis. We enable pharmaceutical companies, CROs and SMOs to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion's Patient Network Explorer also provides a platform for integration of diverse patient data sources into real-world data ecosystems. Clinerion's proprietary technologies comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.
Clinerion website: http://www.clinerion.com
Clinerion's Patient Network Explorer: http://www.clinerion.com/index/PatientNetworkExplorerSolutions.html
For more information, please contact:
Le Vin Chin
Director, Head of Marketing & Communications
Clinerion Ltd
Elisabethenanlage 11, 4051 Basel, Switzerland
Tel.: +41 61 865 60 54
[email protected]
About iHealth Group
The iHealth Group has a multidisciplinary team focused on serving the health informatics industry. Our team has extensive experience in this topic, leading the process of computerization of more than 30 Brazilian hospitals. Digital health transformation will enable us to improve communication with our patients, optimize our queues, improve the safety of our processes, expand our planning capacity, reduce costs, eliminate waste and, especially, do evidence-based management. However, we must understand that it is not the technology, but strategic management that will guide us correctly to the computerization of our health processes. IT cannot be a strategic goal, but an instrument to achieve a goal.
iHealth Group website: http://www.ihealthgroup.com.br
For more information, please contact:
Leonardo Nunes Alegre
iHealth Group
Tel.: +55 51 9 9192-9222
[email protected]
Media Contact
Le Vin Chin, Clinerion Ltd., 41 0618656054, [email protected]
SOURCE Clinerion Ltd.
Share this article